|
Home
>
Newsletters
>
FDAnews Device Daily Bulletin
> St. Jude Warning Letter Possible, CEO Says in 3Q Earnings Call
FDAnews Device Daily Bulletin
Oct. 25, 2012
| Vol.
9 No.
210
St. Jude Warning Letter Possible, CEO Says in 3Q Earnings Call
A warning letter may be in St. Jude Medical’s future, company CEO Dan Starks announced during a Wednesday third quarter earnings call. The company experienced a rough quarter in general, with net sales of $1.3 billion, down 4 percent from the same period in 2011. Revenue overall grew less than 1 percent.
Devices & Diagnostics Letter |
|
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews
All rights reserved. Do not duplicate or redistribute in any form.